| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/23/2004 | WO2004080446A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 09/23/2004 | WO2004080442A1 Extended transdermal contraceptive regimens |
| 09/23/2004 | WO2004080441A1 Patch material for ionic medicine administration |
| 09/23/2004 | WO2004080440A1 Process for the preparing of hardcapsule formulation containing lansoprazole |
| 09/23/2004 | WO2004080439A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 09/23/2004 | WO2004080438A1 Dry polymer and lipid composition |
| 09/23/2004 | WO2004080437A1 Method of delivering substance by transdermal absorption, peeling agent to be used in delivery of substance by transdermal absorption, peeling apparatus and disposable pad for peeling apparatus |
| 09/23/2004 | WO2004080436A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | WO2004080427A2 Method of preventing and treating infections that attack mucosa and assisting rehabilitation thereafter using topically applied ascorbic acid |
| 09/23/2004 | WO2004080419A2 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | WO2004080417A2 Methods and compositions for blocking the calcium cascade |
| 09/23/2004 | WO2004080415A2 Gel composition and method for treatment of vaginal infections |
| 09/23/2004 | WO2004080413A2 Uses and formulations for transdermal or transmucosal application of active agents |
| 09/23/2004 | WO2004080401A2 Oral insulin therapies and protocol |
| 09/23/2004 | WO2004080399A2 Rapidly absorbing lipophilic skin compositions and uses therefor |
| 09/23/2004 | WO2004080397A2 Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent |
| 09/23/2004 | WO2004080396A2 Liposomal curcumin for treatment of cancer |
| 09/23/2004 | WO2004080383A2 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 09/23/2004 | WO2004080382A2 Novel compositions containing fentanyl |
| 09/23/2004 | WO2004080381A2 Impregnated powder improving bioavailability and/or solubility and method of production |
| 09/23/2004 | WO2004080371A2 Injectable isotonic solution of gatifloxacin pre-diluted in glucose. |
| 09/23/2004 | WO2004080210A1 Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea |
| 09/23/2004 | WO2004073682A3 Use of pvp-iodine liposomes for treatment of herpes |
| 09/23/2004 | WO2004069156A3 Inactivated probiotic bacteria and methods of use thereof |
| 09/23/2004 | WO2004069134A3 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 09/23/2004 | WO2004067704A3 Freeze-dried fibrin matrices and methods for preparation thereof |
| 09/23/2004 | WO2004064708A3 Solution for nostril wash |
| 09/23/2004 | WO2004062650A3 Moulded body made from a gelatine-free material filled with a liquid filling |
| 09/23/2004 | WO2004060348A3 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 09/23/2004 | WO2004056320A3 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines |
| 09/23/2004 | WO2004047802A3 Liposomal formulations |
| 09/23/2004 | WO2004047752A3 Pharmaceutical formulations of celcoxib |
| 09/23/2004 | WO2004039430A3 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x |
| 09/23/2004 | WO2004039427A3 Transdermal delivery system for anti-emetic medication |
| 09/23/2004 | WO2004032858A3 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 09/23/2004 | WO2004029137A3 Cross-linked polymer matrices, and methods of making and using same |
| 09/23/2004 | WO2004010944A3 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications |
| 09/23/2004 | WO2003086295A3 Process for preparing tannate liquid and semi-solid dosage forms |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003037312A3 Ribavirin syrup formulations |
| 09/23/2004 | US20040186425 Automatic liquid injection system and method |
| 09/23/2004 | US20040186423 Systems and methods for treating ischemia |
| 09/23/2004 | US20040186405 comprises porous support of woven/non-woven fibers with gel layer containing aromatic and/or balsamic, cosmetic or therapeutic agents |
| 09/23/2004 | US20040186373 Method and device for targeted epithelial delivery of medicinal and related agents |
| 09/23/2004 | US20040186184 Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 09/23/2004 | US20040186183 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 09/23/2004 | US20040186180 Non-steroidal anti-inflammatory drug dosing regimen |
| 09/23/2004 | US20040186179 Pharmaceutical composition |
| 09/23/2004 | US20040186175 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186158 Novel composition of carvedilol |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040186105 admixing low viscosity pregelatinized starch with low water soluble cyclooxygenase-2 inhibitory drug such as celecoxib |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186086 Estetrol and estetrol-like substances have relatively low estrogenic potency, metabolic stability, long half-life; triene steroids |
| 09/23/2004 | US20040186084 Sterile aqueous composition comprising triamcinolone acetonide, and tonicity-adjusting agents, pH-adjusting agents to provide a pH of between about 5 and 7.5; treating diabetic macular edema and related illness; intravitreal injection |
| 09/23/2004 | US20040186076 Pharmaceutical complex |
| 09/23/2004 | US20040186074 including 2-hydroxylpropyl- beta -cyclodextrin for reducing toxicity; a stable, concentrated solution has ifosfamide concentrations as high has 1,1000 mg/ml; antitumor agents |
| 09/23/2004 | US20040186064 additive-free, isotonic inhalant of pH 4.0 to 5.5; improved shelf-life at room temperature; acute and chronic endobronchial infections; cystic fibrosis |
| 09/23/2004 | US20040186048 Gene regulation therapy involving ferritin |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185170 heating/volatilizing taste masking lipidic coating then condensing |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185112 incorporation of a pressure nozzle and a diffuser plate to improve the flow of drying gas and a drying chamber extension to increase drying time, such improvements leading to the formation of homogeneous solid dispersions of drugs in concentration-enhancing polymers |
| 09/23/2004 | US20040185111 Method of preparing biologically active formulations |
| 09/23/2004 | US20040185110 forming a co-dissolved solution of a compatible aid and bioactive agent, and film forming or particle forming so the bioactive agent is crystalline; improved bioavailability of COX-2 inhibitors such as (Z)-3-[1-(4-bromophenyl)-1-(4-methylsulfonylphenyl) methylidene]-dihydrofuran-2-one |
| 09/23/2004 | US20040185109 through the ion exchange of the cationic molecule onto the surface of a substrate having a high surface area; such as a cation/organoclay |
| 09/23/2004 | US20040185108 emulsifying in aqueous solution a solution of a polymer and a drug in a water immiscible solvent to form an oil in water emulsion, freezing and removing aqueous phase by sublimation to form porous polymer drug microparticles, introducing gas; tissue targeted therapy using ultrasound to rupture particles |
| 09/23/2004 | US20040185107 Controlled release oral drug delivery system |
| 09/23/2004 | US20040185105 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 09/23/2004 | US20040185104 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents |
| 09/23/2004 | US20040185103 Methods and compositions for enhanced delivery of bioactive molecules |
| 09/23/2004 | US20040185102 Cholesteryl ester transfer protein (CETP) such as torcetrapib; 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase); improved chemical stability of the HMG-CoA reductase inhibitor |
| 09/23/2004 | US20040185101 Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
| 09/23/2004 | US20040185100 Dosage form with two regions, an extended release region of an NSAID such as diclofenac and an immediate release gastroprotective prostaglandin; osteoarthritis or rheumatoid arthritis; allowing a one a day or twice a day dosing into humans; packaging to minimize oxygen permeation |
| 09/23/2004 | US20040185099 Multiparticulate bisoprolol formulation |
| 09/23/2004 | US20040185098 Making oral dosage form by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules |
| 09/23/2004 | US20040185097 Controlled release modifying complex and pharmaceutical compositions thereof |
| 09/23/2004 | US20040185096 Melt-extrusion multiparticulates |
| 09/23/2004 | US20040185095 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 09/23/2004 | US20040185093 Hydroxypropylmethylcellulose coating agent;sucralose heat-stable, high-intensity sweetener; and menthyl ester non-volatile coolant; taste masking, odorless; drug coatings |
| 09/23/2004 | US20040185092 Enteric coated hard or soft capsule; acid resistance; dissolves in neutral to alkaline media; gastrointestinal disorders |
| 09/23/2004 | US20040185091 High pressure spray-dry of bioactive materials |
| 09/23/2004 | US20040185083 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 09/23/2004 | US20040185068 Self-emulsifying compositions, methods of use and preparation |
| 09/23/2004 | US20040185067 Material delivery method by skin absorption, peeling agent used for material delivery by skin absorption, peeling device, and disposable pad for peeling device |
| 09/23/2004 | US20040185065 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/23/2004 | US20040185055 Transcutaneous immunostimulation |
| 09/23/2004 | US20040185014 comprises chamomile, lemon balm, passion flower, valerian, and melatonin |
| 09/23/2004 | US20040185009 Composition and device for treating periodontal diseases |
| 09/23/2004 | US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 09/23/2004 | US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices |
| 09/23/2004 | US20040185006 Delivery of stimulants through an inhalation route |
| 09/23/2004 | US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 09/23/2004 | US20040185004 Delivery of erectile dysfunction drugs through an inhalation route |
| 09/23/2004 | US20040185003 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 09/23/2004 | US20040185002 condensation aerosol for delivery of a drug selected from chlordiazepoxide, betahistine, clonidine, testosterone, a conjugated estrogen, an estrogen ester, estradiol, an estradiol ester, ethinyl estradiol, an ethinyl estradiol ester and hyoscyamine |
| 09/23/2004 | US20040185001 Delivery of physiologically active compounds through an inhalation route |
| 09/23/2004 | US20040185000 Delivery of antihistamines through an inhalation route |